While not specifically approved for weight loss, many patients with type 2 diabetes experience notable weight reduction, sometimes exceeding 1012% of body weight, particularly at higher doses
Tirzepatide activates two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
targeted, evidence-based support is safer
The body may respond initially, but without foundational repair, there's a heightened risk of plateau, muscle loss, rebound weight gain, or pharmacologic dependency
With continued methodological innovation and mechanistic dissection, they offer a novel class of geroprotective agents that could complement existing approaches to delay senescence and treat agerelated disease
Think of it as the difference between a vitamin C serum and an IV vitamin C push